BAILLIE GIFFORD & CO Q4 2020 Filing
Filed February 10, 2021
Portfolio Value
$179.7M
Holdings
429
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (429 positions)
| Stock | Value |
|---|---|
MDPUSDMeredith Corp | $6K |
BMRNBiomarin Pharmaceutical Inc | $6K |
ATRIUSDAtrion | $6K |
ATEXAnterix | $6K |
—Plantronics Inc | $6K |
ZYXIQZynex | $6K |
—SINA Corp | $6K |
AGXArgan | $5K |
OXMOxford Industries Inc | $5K |
FIXXEURHomology Medicines | $5K |
—Voya Prime Rate Trust | $5K |
37MMRC Global | $4K |
KLDOKaleido Biosciences Inc | $4K |
EXTRExtreme Networks | $4K |
MDXGMiMedx Group | $4K |
HCSGHealthcare Services Group Inc | $4K |
—Vedanta Ltd ADR | $4K |
SOHUSohu.com | $3K |
VRAYQViewRay | $3K |
PBYIPuma Biotechnology | $3K |
ALKSAlkermes Plc | $3K |
—Accelerate Diagnostics | $3K |
TORCEURAdicet Bio Inc | $3K |
AMRXAmneal Pharmaceuticals Inc | $2K |
AAOIApplied Optoelectronics | $2K |
ICPTUSDIntercept Pharmaceuticals Inc | $2K |
NEANuveen Senior Income Fund | $2K |
VNTVontier | $2K |
WECWEC Energy Group | $1K |
CLVSEURClovis Oncology | $1K |
5TCTruecar Inc | $1K |
PreviousPage 5 of 5